Smith & Nephew plc
Smith & Nephew plc scores highest on Earnings (55) and lowest on Nitro (17). Its PosiPenta is 43.29 out of 100, around the middle of similar companies.
On the Penta Grid this week, Smith & Nephew plc is Grid #6 of 8 in the Healthcare sector in United Kingdom, and Grid #81 of 98 in United Kingdom.
Compared with similar companies in the Healthcare sector in United Kingdom.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Smith & Nephew plc | 43.29 | 52 | 55 | 17 | 46 | 46 |
| Convatec Group PLC | 39.93 | 23 | 50 | 64 | 27 | 35 |
| Roivant Sciences Ltd. | 38.43 | 9 | 11 | 68 | 52 | 52 |
| Hikma Pharmaceuticals PLC | 62.00 | 77 | 61 | 61 | 50 | 61 |
| LivaNova PLC | 58.55 | 40 | 63 | 86 | 64 | 40 |
| Haleon plc | 48.21 | 55 | 31 | 50 | 52 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.72 |
| P/B ratio | 2.29 |
EEarnings
| Trailing EPS | ₹69.62 |
| Forward EPS | ₹113.79 |
NNitro
| Price | 1372.83 |
| 52-week high | 1805.87 |
| 52-week low | 1241.05 |
| Fall from 52-week high | 24.0% |
TTorque
| Return on equity (ROE) | 11.85% |
| Debt-to-equity | 0.73 |
AAnchor
| Beta (price swings) | 0.67 |
| Market cap | ₹1,14,910 Cr |
| Insider holding | 0.24% |
| Dividend yield | 2.72% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Smith & Nephew plc's PosiPenta score?
Smith & Nephew plc's PosiPenta is 43.29 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Smith & Nephew plc stand on the Penta Grid?
On the Penta Grid this week, Smith & Nephew plc is Grid #6 of 8 in the Healthcare sector in United Kingdom, and Grid #81 of 98 in United Kingdom.
Which PosiPenta pillar is strongest for Smith & Nephew plc?
Earnings (growth), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Smith & Nephew plc?
Nitro (momentum), with a score of 17 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.